{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:15:11Z","timestamp":1792012511588,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejmech.2020.113064","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T20:01:46Z","timestamp":1606766506000},"page":"113064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Ruthenium compounds as potential therapeutic agents for type 2 diabetes mellitus"],"prefix":"10.1016","volume":"213","author":[{"given":"Sanam","family":"Maikoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-7597","authenticated-orcid":false,"given":"Daniel","family":"Makayane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-5978","authenticated-orcid":false,"given":"Irvin Noel","family":"Booysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phikelelani","family":"Ngubane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andile","family":"Khathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.113064_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.04.061","article-title":"Current anti-diabetic agents and their molecular targets: a review","volume":"152","author":"Kerru","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113064_bib2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.numecd.2020.06.003","article-title":"The contribution of physical inactivity and socioeconomic factors to type 2 diabetes in Nepal: a structural equation modelling analysis","volume":"30","author":"Paudel","year":"2020","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.ejmech.2020.113064_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s13668-018-0244-z","article-title":"Dietary fat and risk for type 2 diabetes: a review of recent research","volume":"7","author":"Bradley","year":"2018","journal-title":"Current Nutrition Reports"},{"key":"10.1016\/j.ejmech.2020.113064_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/03630260903212175","article-title":"Oxidative stress, diabetes, and diabetic complications","volume":"33","author":"Wei","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ejmech.2020.113064_bib5","doi-asserted-by":"crossref","first-page":"100132","DOI":"10.1016\/j.obmed.2019.100132","article-title":"Diabetes in Ethiopia: a systematic review of prevalence, risk factors, complications, and cost","volume":"15","author":"Bishu","year":"2019","journal-title":"Obesity Medicine"},{"key":"10.1016\/j.ejmech.2020.113064_bib6","doi-asserted-by":"crossref","first-page":"108053","DOI":"10.1016\/j.diabres.2020.108053","article-title":"The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives","volume":"161","author":"Ceriello","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2020.113064_bib8","first-page":"LC18","article-title":"Association between socioeconomic status and diabetes mellitus: the national socioeconomics survey, 2010 and 2012","volume":"11","author":"Suwannaphant","year":"2017","journal-title":"J.\u00a0Clin. Diagn. Res."},{"key":"10.1016\/j.ejmech.2020.113064_bib9","first-page":"1636","article-title":"Effect of socioeconomic factors and family history on the incidence of diabetes in an adult diabetic population from Algeria","volume":"45","author":"Ferdi","year":"2016","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.ejmech.2020.113064_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211208","article-title":"Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: a decomposition analysis","volume":"14","author":"Mutyambizi","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113064_bib11","article-title":"Intermediate hyperglycaemia, insulin resistance and metabolic syndrome among obese Arab children (12\u201317 years old) in Kuwait","author":"Davidsson","year":"2020","journal-title":"Primary Care Diabetes"},{"key":"10.1016\/j.ejmech.2020.113064_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/00325481.2019.1643635","article-title":"Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality","volume":"131","author":"Mendez","year":"2019","journal-title":"PGM (Postgrad. Med.)"},{"key":"10.1016\/j.ejmech.2020.113064_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MED.0b013e3283557cd5","article-title":"Insulin resistance in type 2 diabetic youth","volume":"19","author":"Mizokami-Stout","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejmech.2020.113064_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jinorgbio.2015.01.002","article-title":"Controlling diabetes by chromium complexes: the role of the ligands","volume":"146","author":"Peng","year":"2015","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of Metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2020.113064_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/B817203J","article-title":"A\u00a0perspective on the role of metals in diabetes: past findings and possible future directions","volume":"1","author":"Meyer","year":"2009","journal-title":"Metall"},{"key":"10.1016\/j.ejmech.2020.113064_bib17","doi-asserted-by":"crossref","first-page":"111094","DOI":"10.1016\/j.jinorgbio.2020.111094","article-title":"Vanadium and insulin: partners in metabolic regulation","volume":"208","author":"Trevi\u00f1o","year":"2020","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jinorgbio.2018.11.004","article-title":"Interaction of amylin species with transition metals and membranes","volume":"191","author":"Alghrably","year":"2019","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib19","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1039\/c1dt10380f","article-title":"Metal-based anti-diabetic drugs: advances and challenges","volume":"40","author":"Levina","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2020.113064_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1055\/s-2007-973893","article-title":"Exploring chemical space with organometallics: ruthenium complexes as protein kinase inhibitors","volume":"2007","author":"Meggers","year":"2007","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2020.113064_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00775-019-01637-6","article-title":"Influence of methionine\u2013ruthenium complex on the fibril formation of human islet amyloid polypeptide","volume":"24","author":"Gong","year":"2019","journal-title":"JBIC Journal of Biological Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib22","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1039\/c1dt11189b","article-title":"Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide\u2014a model for the active-site cysteine of protein tyrosine phosphatase 1B","volume":"40","author":"Han","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2020.113064_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.physbeh.2016.05.052","article-title":"Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats","volume":"164","author":"Jain","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejmech.2020.113064_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2005.10.039","article-title":"The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes","volume":"528","author":"Hutchings","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.113064_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2013.11.021","article-title":"Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV","volume":"99","author":"Antonyan","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2020.113064_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00775-019-01683-0","article-title":"Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study","volume":"24","author":"D\u00f6m\u00f6t\u00f6r","year":"2019","journal-title":"JBIC Journal of Biological Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib27","first-page":"1","article-title":"Ruthenium anticancer agents\u2014from cisplatin analogues to rational drug design","author":"Muneebah","year":"2017","journal-title":"Encyclopedia of Inorganic and Bioinorganic Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.113064_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2016.08.001","article-title":"Interactions between proteins and Ru compounds of medicinal interest: a structural perspective","volume":"326","author":"Merlino","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.113064_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/inorganics7030031","article-title":"Designing ruthenium anticancer drugs: what have we learnt from the key drug candidates?","volume":"7","author":"Coverdale","year":"2019","journal-title":"INORGA"},{"key":"10.1016\/j.ejmech.2020.113064_bib31","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1039\/C7CS00195A","article-title":"The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials","volume":"46","author":"Zeng","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.113064_bib32","first-page":"1","article-title":"Ruthenium complexes with mono- or bis-heterocyclic chelates: DNA\/BSA binding, antioxidant and anticancer studies","author":"Maikoo","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2020.113064_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2018.07.012","article-title":"Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents","volume":"376","author":"Brabec","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.113064_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1039\/C9MD00573K","article-title":"Vascular tone and angiogenesis modulation by catecholamine coordinated to ruthenium","volume":"11","author":"Alves","year":"2020","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jinorgbio.2018.11.018","article-title":"Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite","volume":"191","author":"Stringer","year":"2019","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib36","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) compounds: next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113064_bib37","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1039\/D0SC03410J","article-title":"Mononuclear ruthenium(ii) theranostic complexes that function as broad-spectrum antimicrobials in therapeutically resistant pathogens through interaction with DNA","volume":"11","author":"Smitten","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2020.113064_bib38","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1039\/c1dt11007a","article-title":"Targeted and multifunctional arene ruthenium chemotherapeutics","volume":"40","author":"Smith","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2020.113064_bib39","doi-asserted-by":"crossref","first-page":"111104","DOI":"10.1016\/j.jinorgbio.2020.111104","article-title":"Development of four ruthenium polypyridyl complexes as antitumor agents: design, biological evaluation and mechanism investigation","volume":"208","author":"Jiang","year":"2020","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jinorgbio.2018.03.013","article-title":"New (arene)ruthenium(II) complexes of 4-aryl-4H-naphthopyrans with anticancer and anti-vascular activities","volume":"184","author":"Schmitt","year":"2018","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinorgbio.2017.07.006","article-title":"New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: playing with auxiliary ligands for tuning the mechanism of biological activity","volume":"175","author":"\u0141omzik","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib42","doi-asserted-by":"crossref","first-page":"18512","DOI":"10.1039\/C6RA28107A","article-title":"Binuclear ruthenium complexes inhibit the fibril formation of human islet amyloid polypeptide","volume":"7","author":"Gong","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.113064_bib43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1039\/c3mt00146f","article-title":"Ruthenium complexes as novel inhibitors of human islet amyloid polypeptide fibril formation","volume":"5","author":"He","year":"2013","journal-title":"Metall"},{"key":"10.1016\/j.ejmech.2020.113064_bib44","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1039\/C4RA15152F","article-title":"Ruthenium complexes as inhibitors of human islet amyloid polypeptide aggregation, an effect that prevents beta cell apoptosis","volume":"5","author":"Ma","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.113064_bib45","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/ja1007867","article-title":"Role of zinc in human islet amyloid polypeptide aggregation","volume":"132","author":"Brender","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113064_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jinorgbio.2017.02.008","article-title":"Disaggregation of human islet amyloid polypeptide fibril formation by ruthenium polypyridyl complexes","volume":"170","author":"Zhu","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ccr.2018.04.007","article-title":"Cu and Zn coordination to amyloid peptides: from fascinating chemistry to debated pathological relevance","volume":"371","author":"Atri\u00e1n-Blasco","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.113064_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122269","article-title":"Vanadium compounds as PTP inhibitors","volume":"22","author":"Irving","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.113064_bib49","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1021\/ic301884j","article-title":"Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B","volume":"51","author":"Ong","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2020.113064_bib50","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cmet.2019.02.012","article-title":"Phosphoproteomics reveals the GSK3-PDX1 Axis as a key pathogenic signaling node in diabetic islets","volume":"29","author":"Sacco","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2020.113064_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/thno.14334","article-title":"Glycogen synthase kinase-3 (GSK-3)-Targeted therapy and imaging","volume":"6","author":"Pandey","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2020.113064_bib52","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2020.113064_bib53","first-page":"381029","article-title":"Small-Molecule inhibitors of GSK-3: structural insights and their application to alzheimer\u2019s disease models","volume":"2012","author":"Kramer","year":"2012","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ejmech.2020.113064_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/ol036283s","article-title":"Ruthenium complexes as protein kinase inhibitors","volume":"6","author":"Zhang","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2020.113064_bib55","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cbic.200600117","article-title":"Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3","volume":"7","author":"Atilla-Gokcumen","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.113064_bib56","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1021\/ol0620646","article-title":"Ruthenium half-sandwich complexes as protein kinase Inhibitors: an N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety","volume":"8","author":"Bregman","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2020.113064_bib57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/ja055523r","article-title":"Rapid access to unexplored chemical space by ligand scanning around a ruthenium Center: discovery of potent and selective protein kinase inhibitors","volume":"128","author":"Bregman","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113064_bib58","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/cbic.200800489","article-title":"Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3","volume":"9","author":"Atilla-Gokcumen","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.113064_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00775-010-0699-x","article-title":"Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3\u03b2","volume":"16","author":"Atilla-Gokcumen","year":"2011","journal-title":"JBIC Journal of Biological Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib60","doi-asserted-by":"crossref","first-page":"15764","DOI":"10.1021\/ja805555a","article-title":"Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes","volume":"130","author":"Maksimoska","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113064_bib61","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1021\/ja1112996","article-title":"Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors","volume":"133","author":"Feng","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113064_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071721","article-title":"Effects of a ruthenium Schiff base complex on glucose homeostasis in diet-induced pre-diabetic rats","volume":"23","author":"Mabuza","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.113064_bib63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.poly.2014.05.021","article-title":"Novel ruthenium(II) and (III) compounds with multidentate Schiff base chelates bearing biologically significant moieties","volume":"79","author":"Booysen","year":"2014","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2020.113064_bib64","doi-asserted-by":"crossref","first-page":"114569","DOI":"10.1016\/j.poly.2020.114569","article-title":"Synthetic, characterization and cytotoxic studies of ruthenium complexes with Schiff bases encompassing biologically relevant moieties","volume":"184","author":"Maikoo","year":"2020","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2020.113064_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/DMSO.S183811","article-title":"Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats","volume":"12","author":"Mabuza","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ejmech.2020.113064_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.curtheres.2019.100570","article-title":"Hepatoprotective effects of a ruthenium(II) Schiff base complex in rats with diet-induced prediabetes","volume":"91","author":"Mabuza","year":"2019","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejmech.2020.113064_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejmech.2018.03.041","article-title":"Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113064_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CAD.0b013e328322fbc5","article-title":"Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study","volume":"20","author":"Lentz","year":"2009","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2020.113064_bib69","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1039\/C7OB00724H","article-title":"Probing the pharmacokinetics of cucurbit[7, 8 and 10]uril: and a dinuclear ruthenium antimicrobial complex encapsulated in cucurbit[10]uril","volume":"15","author":"Li","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.113064_bib70","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: new horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2020.113064_bib71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jddst.2018.01.016","article-title":"Tetrahydro curcumin loaded PCL-PEG electrospun transdermal nanofiber patch: preparation, characterization, and in\u00a0vitro diffusion evaluations","volume":"44","author":"Ravikumar","year":"2018","journal-title":"J.\u00a0Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2020.113064_bib72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41570-019-0088-0","article-title":"Polymer encapsulation of ruthenium complexes for biological and medicinal applications","volume":"3","author":"Villemin","year":"2019","journal-title":"Nature Reviews Chemistry"},{"key":"10.1016\/j.ejmech.2020.113064_bib73","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tem.2020.02.001","article-title":"Nanomedicine-based strategies for diabetes: diagnostics, monitoring, and treatment","volume":"31","author":"Lemmerman","year":"2020","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2020.113064_bib74","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jinorgbio.2006.08.016","article-title":"Vanadium in diabetes: 100 years from phase 0 to phase I","volume":"100","author":"Thompson","year":"2006","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.113064_bib75","doi-asserted-by":"crossref","first-page":"119445","DOI":"10.1016\/j.ica.2020.119445","article-title":"The potentiality of vanadium in medicinal applications","volume":"504","author":"Rehder","year":"2020","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2020.113064_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fct.2016.07.005","article-title":"Vanadium compounds for the treatment of human diabetes mellitus: a scientific curiosity? A review of thirty years of research","volume":"95","author":"Domingo","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2020.113064_bib77","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:52Z","timestamp":1759329052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420310369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":76,"alternative-id":["S0223523420310369"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113064","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruthenium compounds as potential therapeutic agents for type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113064"}}